These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Rioprostil prevents aspirin-induced fecal blood loss in dogs. Correlation of Hemoquant (Hb) with endoscopic findings. Katz LB; Fernandez JA; Schwartz S; Shriver DA Digestion; 1989; 42(4):217-23. PubMed ID: 2509266 [TBL] [Abstract][Full Text] [Related]
12. Gastric mucosal blood flow and neutrophil activation in aspirin-induced gastric mucosal damage in man. Konturek JW; Dembinski A; Stoll R; Konturek M; Domschke W Scand J Gastroenterol; 1993 Sep; 28(9):767-71. PubMed ID: 8235431 [TBL] [Abstract][Full Text] [Related]
13. Chronic beta-carotene supplementation does not alter the gastric mucosal response to acute aspirin ingestion. Moses FM; Kikendall JW; Bowen P; Young TR J Clin Gastroenterol; 1990 Jun; 12(3):267-70. PubMed ID: 2362094 [TBL] [Abstract][Full Text] [Related]
14. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645 [TBL] [Abstract][Full Text] [Related]
15. Do infiltrating leukocytes contribute to the adaptation of human gastric mucosa to continued aspirin administration? Stachura J; Konturek JW; Dembinski A; Domschke W Scand J Gastroenterol; 1994 Nov; 29(11):966-72. PubMed ID: 7871375 [TBL] [Abstract][Full Text] [Related]
16. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction. Nema H; Kato M J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. Lanza FL; Royer GL; Nelson RS N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762 [No Abstract] [Full Text] [Related]
18. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin. Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156 [TBL] [Abstract][Full Text] [Related]
19. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day. Lanza FL; Rack MF; Wagner GS; Balm TK Dig Dis Sci; 1985 Jun; 30(6):509-12. PubMed ID: 3873326 [TBL] [Abstract][Full Text] [Related]
20. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Silvoso GR; Ivey KJ; Butt JH; Lockard OO; Holt SD; Sisk C; Baskin WN; Mackercher PA; Hewett J Ann Intern Med; 1979 Oct; 91(4):517-20. PubMed ID: 314764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]